abstract |
The present invention provides a novel humanized IL-32 binding molecule, in particular human anti-IL-32 antibody and IL-32 binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits and methods for diagnosis and therapy are described. |